PURPOSE: The aim of this study was to investigate the prognostic significance of the response of primary rectal lesions to preoperative radiotherapy, pathological nodal status, and carcinoembryonic antigen (CEA) levels before and after radiotherapy in rectal cancer patients treated with a total mesorectal excision. METHODS: We investigated the prognostic significance of the clinical and pathological factors in 97 patients treated with preoperative radiotherapy (50-50.4 Gy over 5-6 weeks) followed by curative resections. RESULTS: A high CEA level (>5 ng/mL) after radiotherapy (hazard ratio, 2.849; 95% confidence interval, 1.061-7.651; p = 0.0377) and pathological lymph node metastasis (hazard ratio, 0.350; 95% confidence interval, 0.154-0.797; p = 0.0124) were independently associated with postoperative recurrence. Although the CEA level before radiotherapy was associated with disease-free survival in a univariate analysis, it lost its statistical significance in a multivariate analysis. The response of the primary rectal lesions, evaluated pathologically by T stage and the degree of regression, was not associated with disease-free survival. In patients without lymph node metastasis, the 5-year disease-free survival of those with a high CEA level after radiotherapy was significantly worse than those with low CEA after radiotherapy (61.6% vs. 89.0%, respectively, p = 0.0234). CONCLUSIONS: Pathological lymph node metastasis and a high CEA level after radiotherapy were independent predictors of a poor outcome in rectal cancer patients treated with preoperative radiotherapy. The CEA level after radiotherapy was capable of discriminating patients with a high risk of recurrence among pathologically node-negative patients.
PURPOSE: The aim of this study was to investigate the prognostic significance of the response of primary rectal lesions to preoperative radiotherapy, pathological nodal status, and carcinoembryonic antigen (CEA) levels before and after radiotherapy in rectal cancerpatients treated with a total mesorectal excision. METHODS: We investigated the prognostic significance of the clinical and pathological factors in 97 patients treated with preoperative radiotherapy (50-50.4 Gy over 5-6 weeks) followed by curative resections. RESULTS: A high CEA level (>5 ng/mL) after radiotherapy (hazard ratio, 2.849; 95% confidence interval, 1.061-7.651; p = 0.0377) and pathological lymph node metastasis (hazard ratio, 0.350; 95% confidence interval, 0.154-0.797; p = 0.0124) were independently associated with postoperative recurrence. Although the CEA level before radiotherapy was associated with disease-free survival in a univariate analysis, it lost its statistical significance in a multivariate analysis. The response of the primary rectal lesions, evaluated pathologically by T stage and the degree of regression, was not associated with disease-free survival. In patients without lymph node metastasis, the 5-year disease-free survival of those with a high CEA level after radiotherapy was significantly worse than those with low CEA after radiotherapy (61.6% vs. 89.0%, respectively, p = 0.0234). CONCLUSIONS: Pathological lymph node metastasis and a high CEA level after radiotherapy were independent predictors of a poor outcome in rectal cancerpatients treated with preoperative radiotherapy. The CEA level after radiotherapy was capable of discriminating patients with a high risk of recurrence among pathologically node-negative patients.
Authors: C C Compton; L P Fielding; L J Burgart; B Conley; H S Cooper; S R Hamilton; M E Hammond; D E Henson; R V Hutter; R B Nagle; M L Nielsen; D J Sargent; C R Taylor; M Welton; C Willett Journal: Arch Pathol Lab Med Date: 2000-07 Impact factor: 5.534
Authors: Jeong Yeon Kim; Nam Kyu Kim; Seung Kook Sohn; Yong Wan Kim; Kim Jin Soo Kim; Hyuk Hur; Byung Soh Min; Chang Hwan Cho Journal: Ann Surg Oncol Date: 2009-08-06 Impact factor: 5.344
Authors: Melanie Spitzner; Birte Roesler; Christian Bielfeld; Georg Emons; Jochen Gaedcke; Hendrik A Wolff; Margret Rave-Fränk; Frank Kramer; Tim Beissbarth; Julia Kitz; Jürgen Wienands; B Michael Ghadimi; Reinhard Ebner; Thomas Ried; Marian Grade Journal: Int J Cancer Date: 2013-09-03 Impact factor: 7.396
Authors: Jochen Gaedcke; Andreas Leha; Rainer Claus; Dieter Weichenhan; Klaus Jung; Julia Kitz; Marian Grade; Hendrik A Wolff; Peter Jo; Jérôme Doyen; Jean-Pierre Gérard; Steven A Johnsen; Christoph Plass; Tim Beißbarth; Michael Ghadimi Journal: Oncotarget Date: 2014-09-30